Vincere Biosciences

📍 Cambridge, United States🗓 Founded 2018👥 9 employees💰 Last funded 2021
Biotechnology Research🌐 vincerebio.com
Website LinkedIn
Vincere Biosciences is dedicated to conquering age-related diseases through the development of small molecule therapeutics empowered by a suite of computational tools alongside traditional biology and drug discovery expertise. Our innovative approach focuses on developing small molecules that enhance the removal of damaged mitochondria by modulating mitochondrial quality control mechanisms, such as mitophagy. With the potential to be groundbreaking, these small molecules could become the world's first-ever medicines capable of slowing down or even halting the progression of debilitating conditions like Parkinson's disease and other age-related diseases. By doing so, we aim to transform the lives of hundreds of millions of patients across the globe. We welcome you to follow our page for more content about our company, our dedicated team, and the science that drives what we do.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2018
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Vincere Biosciences?
Vincere Biosciences has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Vincere Biosciences last raise funding?
The most recent investment in Vincere Biosciences recorded on gritt.io was in 2021.
When was Vincere Biosciences founded?
Vincere Biosciences was founded in 2018.
What industry is Vincere Biosciences in?
Vincere Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Vincere Biosciences based?
Vincere Biosciences is headquartered in Cambridge, United States.